Therapeutic delivery · 2026
Ternary co-encapsulation in electrospun PVA fibers: release kinetics and mechanisms.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Monroy Andrea Ximena Esparza, Galindo Rebeca Betancourt, Pérez Antonio Serguei Ledezma, De León Santillán Arxel, Neira Roberto Espinoza, Canché Carmen Natividad Alvarado, González Christian Chapa, García-Casillas Perla Elvia
Аннотация
AIMS: This study aimed to develop and evaluate a ternary co-encapsulation system based on electrospun poly(vinyl alcohol) (PVA) nanofibers containing Aloe vera extract, methylglyoxal (MGO), and collagen for multifunctional wound-healing applications with controlled therapeutic delivery.
MATERIALS AND METHODS: Electrospun nanofibers were characterized by scanning electron microscopy and FTIR spectroscopy. Swelling, degradation, and in vitro release profiles were evaluated under physiological conditions. Release kinetics were analyzed using Korsmeyer-Peppas and Weibull models. Antimicrobial activity against Escherichia coli and Staphylococcus aureus was assessed according to JIS Z 2801. Cytocompatibility was evaluated using human fibroblast cultures following ISO 10993-5 guidelines.
RESULTS: The co-encapsulated nanofibers exhibited homogeneous morphology with fiber diameters of 350-500 nm and preserved bioactive agents´ integrity. The system showed a biphasic release profile, with rapid Aloe vera release (~80% within 4 h) followed by sustained MGO and collagen release up to 160 h. Release behavior involved coupled diffusion, polymer relaxation, and partial matrix dissolution. The ternary system demonstrated strong antimicrobial activity, achieving approximately 99.4% inhibition of E. coli, while maintaining excellent cytocompatibility with cell viability above 100%.
CONCLUSIONS: The ternary co-encapsulation strategy synergistic antimicrobial and regenerative effects through controlled multi-agent delivery in electrospun PVA wound-dressing platforms.
MATERIALS AND METHODS: Electrospun nanofibers were characterized by scanning electron microscopy and FTIR spectroscopy. Swelling, degradation, and in vitro release profiles were evaluated under physiological conditions. Release kinetics were analyzed using Korsmeyer-Peppas and Weibull models. Antimicrobial activity against Escherichia coli and Staphylococcus aureus was assessed according to JIS Z 2801. Cytocompatibility was evaluated using human fibroblast cultures following ISO 10993-5 guidelines.
RESULTS: The co-encapsulated nanofibers exhibited homogeneous morphology with fiber diameters of 350-500 nm and preserved bioactive agents´ integrity. The system showed a biphasic release profile, with rapid Aloe vera release (~80% within 4 h) followed by sustained MGO and collagen release up to 160 h. Release behavior involved coupled diffusion, polymer relaxation, and partial matrix dissolution. The ternary system demonstrated strong antimicrobial activity, achieving approximately 99.4% inhibition of E. coli, while maintaining excellent cytocompatibility with cell viability above 100%.
CONCLUSIONS: The ternary co-encapsulation strategy synergistic antimicrobial and regenerative effects through controlled multi-agent delivery in electrospun PVA wound-dressing platforms.